Test Price
2,800 AED✅ Home Collection Available
SLC24A5 Gene Oculocutaneous Nonsyndromic Albinism Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SLC24A5 للبرص العيني الجلدي غير المتلازمي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يقدم هذا التحليل تسلسل الجيل التالي (NGS) لتحديد طفرات جين SLC24A5 المرتبطة بالبرص العيني الجلدي غير المتلازمي، بدقة تشخيصية تصل إلى 99.9% عبر مختبر معتمد من الأيزو.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
This Next-Generation Sequencing (NGS) test analyzes the SLC24A5 gene to confirm or rule out oculocutaneous nonsyndromic albinism (OCA6). In parallel, يُجرى التحليل للكشف عن الطفرات المسببة للالبرص العيني الجلدي غير المتلازمي.
| Feature | Our Test (NGS‑OCA6) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Full gene coverage, CNV & SNV | Limited to known hotspots |
| Methodology | Illumina NGS with bioinformatic validation | Sanger sequencing |
| Turnaround | 3-4 Weeks | 4-6 Weeks |
Physician Insight & Safety Protocol
"As an ophthalmologist managing inherited retinal disorders, I emphasise that a positive SLC24A5 variant must be correlated with clinical ophtalmologic and dermatologic findings. This test does not replace a full clinical evaluation, and results should guide a personalised management plan." – Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Medication & Pre‑test Warning
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusions & Emergency Red Flags
- Individuals under 18 years without guardian consent (Federal Decree‑Law No. 41 of 2024 & CDS Law 2026).
- Inability to provide informed consent or severe cognitive impairment.
- Active bleeding disorder or anticoagulant use that precludes even a capillary blood spot (FTA card).
- If you experience sudden vision loss, severe eye pain, or signs of allergic reaction post‑collection, seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the SLC24A5 NGS test detect, and who should consider it?
This identifies pathogenic variants in the SLC24A5 gene responsible for oculocutaneous nonsyndromic albinism type 6 (OCA6). It is indicated for individuals with clinical signs of albinism (photophobia, nystagmus, hypopigmented fundi) and a family history suggestive of autosomal recessive inheritance, or for those undergoing genetic counselling.
2. How is the sample collected, and is fasting required?
A certified phlebotomist collects either 2–3 mL of whole blood in an EDTA tube, extracted DNA, or a few drops of blood on an FTA card during our home visit (8 AM – 11 PM). Fasting is not required, and usual medications can be continued unless your physician instructs otherwise.
3. هل يغطي التأمين الصحي هذا التحليل في الإمارات؟
نعم، تقدم العديد من شركات التأمين في الإمارات تغطية لهذا التحليل الجيني عند وجود ضرورة طبية. أرسل صورة بطاقة التأمين الخاصة بك عبر واتساب على الرقم +971545488731 للتحقق من الأهلية قبل الموعد.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians